Convocatorias Vigentes

Fecha de cierre: 1pm on 16 July 2020

Objetivo: The NIHR Policy Research Programme (NIHR PRP) invites applications for research to inform the policy response to challenges posed by COVID-19; and to capture learning arising from the pandemic. 

Líneas temáticas:

The research specification document sets out the need for research in specific topic areas to inform medium- to longer-term policy decisions for health and social care resulting from COVID-19: https://bit.ly/3ePxs7I 

Requisitos:

- Application Summary Information
- Lead Applicant CV
- Lead Applicant Research Background
- The Research Team (Specify your (lead applicant) role in this research)
- Plain English Summary of Research
- Research Plan

Tipo de financiación: Research

➡️ Más información: https://bit.ly/2ZmXOHy 

Fecha de apertura junio 22 de 2020
Fecha de cierre: julio 22 de 2020

Objetivo: The purpose of the FOA is to establish Serological Sciences Research Projects with the goals of:
identifying and advancing research opportunities to characterize the immune responses elicited by SARS-CoV-2 viral infection; understanding the mechanisms driving the serological, humoral and cellular immune responses; determining host, genetic, and environmental modifiers of the immune response; and determining the serological correlates of disease pathogenesis and protection against future infection; defining access, communication, and implementation barriers related to SARS-CoV-2 serological testing.

Líneas temáticas: 
- Understanding the mechanisms underlying innate, cell-mediated, and humoral immune responses to SARS-CoV-2 – including macrophage activating syndrome and cytokine storm - as well as how disease severity differs as a function of immune health status.

- Determine if therapeutics (e.g. remdesivir, antivirals) and passive antibody therapies used to treat COVID-19 modulate serologic and immune responses to SARS-CoV-2 (e.g. antibody-dependent enhancement).
- Characterizing the serologic differences resulting from natural infection vs. vaccination against SARS-CoV-2, and how they correlate with the persistence or longevity of the response.

- Identifying genetic and epigenetic determinants (e.g. HLA types) that modulate the development and durability of immune responses against SARS-CoV-2 infection and associated serological correlates.

- Understanding what factors affect the SARS-CoV-2 immune response or pathogenesis including SARS-CoV-2 viral load, health conditions (e.g., diabetes, obesity, cardiovascular disease, precancerous conditions), co-infection with other viruses (e.g., HIV, HPV, CMV), or the presence of endemic coronavirus antibodies.

Understanding how precancerous conditions, cancer, and/or cancer therapies (i.e., chemotherapy, radiation, immunotherapy, hormonal therapy, combinations) affect serologic and immune responses to SARS-CoV-2 infection and the clinical course of infection, and conversely how the immune response to SARS-CoV-2 affects precancerous conditions, cancers, and responses to cancer therapies.

- Understanding how patient demographic factors (e.g., age, sex, ethnicity), behavioral (e.g., smoking, physical activity), and environmental factors affect immune or serological responses to SARS-CoV-2 infection.
- Researching the clinical and public health implementation of validated serologic assays, their interpretation, and follow-up for health outcomes.

- Approaches to promoting and ensuring equitable access to serologic testing, identification of contextual factors associated with the uptake of SARS-CoV-2 serologic testing, and whether differential access further exacerbates health disparities and health outcomes.

- Determining the ethical, legal and social implications of serologic testing for SARS-CoV-2 in diverse populations and the best methods for appropriate communication of results and interpretation at the individual, provider, and population level; for example, the impact of serologic testing on employment, housing, health insurance, access to federal benefits.

Requisitos: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Applicant organizations must complete and maintain the registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award.
Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement , and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide.

Tipo de financiación: the period of the award is 5 years. Application budgets are limited to $500,000 Direct Costs (exclusive of third-party facilities and administration [F&A] costs) and need to reflect the actual needs of the proposed project.

➡️ Más información: https://bit.ly/3hgOXzu

Fecha de apertura junio 22 de 2020
Fecha de cierre: julio 22 de 2020

Objetivo: The purpose of the FOA is to establish Serological Sciences Research Projects with the goals of:
identifying and advancing research opportunities to characterize the immune responses elicited by SARS-CoV-2 viral infection; understanding the mechanisms driving the serological, humoral and cellular immune responses; determining host, genetic, and environmental modifiers of the immune response; and determining the serological correlates of disease pathogenesis and protection against future infection; defining access, communication, and implementation barriers related to SARS-CoV-2 serological testing.

Líneas temáticas:

- Developing novel assays, and preclinical and computational model systems to test adaptive and innate immune responses to SARS-CoV-2 infection that inform immune parameters and serological markers associated with asymptomatic vs. symptomatic infection, disease severity, risk of re-infection, or vaccine efficacy.

- Understanding the mechanisms underlying innate, cell-mediated, and humoral immune responses to SARS-CoV-2 – including macrophage activating syndrome and cytokine storm - as well as how disease severity differs as a function of immune health status.

- Determine if therapeutics (e.g., remdesivir, antivirals) and passive antibody therapies used to treat COVID-19 modulate serologic and immune responses to SARS-CoV-2 (e.g., antibody-dependent enhancement).

- Characterizing the serologic differences resulting from natural infection vs. vaccination against SARS-CoV-2, and how they correlate with the persistence or longevity of the response.

- Identifying genetic and epigenetic determinants (e.g., HLA types) that modulate the development and durability of immune responses against SARS-CoV-2 infection and associated serological correlates.

- Understanding what factors affect the SARS-CoV-2 immune response or pathogenesis including SARS-CoV-2 viral load, health conditions (e.g., diabetes, obesity, cardiovascular disease, precancerous conditions), co-infection with other viruses (e.g., HIV, HPV, CMV), or the presence of endemic coronavirus antibodies.

- Understanding how precancerous conditions, cancer, and/or cancer therapies (i.e., chemotherapy, radiation, immunotherapy, hormonal therapy, combinations) affect serologic and immune responses to SARS-CoV-2 infection and the clinical course of infection, and conversely how the immune response to SARS-CoV-2 affects precancerous conditions, cancers, and responses to cancer therapies.

- Understanding how patient demographic factors (e.g., age, sex, ethnicity), behavioral (e.g., smoking, physical activity), and environmental factors affect immune or serological responses to SARS-CoV-2 infection.
- Researching the clinical and public health implementation of validated serologic assays, their interpretation, and follow-up for health outcomes.

- Approaches to promoting and ensuring equitable access to serologic testing, identification of contextual factors associated with the uptake of SARS-CoV-2 serologic testing, and whether differential access further exacerbates health disparities and health outcomes.

- Determining the ethical, legal and social implications of serologic testing for SARS-CoV-2 in diverse populations and the best methods for appropriate communication of results and interpretation at the individual, provider, and population level; for example, the impact of serologic testing on employment, housing, health insurance, access to federal benefits.

Requisitos: Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Applicant organizations must complete and maintain the registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award.
Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement , and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide.

Tipo de financiación: Research

➡️ Más información: https://bit.ly/3bwjuFd

Fecha de cierre: 31 August 2020

Objetivo: The research grants program is open to scientists in all career stages who are affiliated with any research-based institution, university or company. Applicants submit their application for the focus topics containing non-confidential information only.

Líneas temáticas:

Pandemic preparedness / fighting new emerging viral infectious disease

Requisitos: 

- Submissions are accepted from scientists in all countries all over the world.
-To submit an application, investigators must first register with our online portal.

Tipo de financiación: Research

➡️ Más información: https://bit.ly/2Tmvzqv

Fecha de cierre: 10/8/2020 

Objetivo: to support applied health research that will address COVID-19 knowledge gaps.  The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income countries (LMIC) contexts.The call specification is based on the WHO COVID-19 Global Research Roadmap priorities identified through a consultative process that involved experts from across the world. 

Líneas temáticas:

1. Generate high-quality evidence to achieving the goals of the strategic public health response plan.
2. Promote the prioritisation of knowledge needs according to epidemic dynamics.
3. Promote that knowledge is produced according to local, national and regional needs.
4. Promote that knowledge outputs and methodological limitations are easily understood by non-social scientists.
5. Develop guidelines and Standard Operating Procedures (SOPs) to operationalise epidemic mitigation mechanisms.
6. Engage with communities to bring their voices to research and decision-making processes.
7. To understand cultural, long-term, and non-intended consequences of epidemic-control decisions.
8. Understand how decisions in the field may inadvertently undermine response goals.
9. Document how COVID-19 and the health system response affects the supply and access to other health care provision (such as maternal health, immunisation, routine surgeries, chronic disease care etc); and determining strategies to mitigate this.
10. Effective health systems responses to the epidemic: addressing issues such as health, wellbeing and effectiveness of the health workforce; supply chain management, financing, optimal implementation of clinical management and infection control measures.
11. Understanding and mitigating contextual vulnerability of health systems.

Requisitos:

- Applications are particularly encouraged from LMIC PIs, as well as PIs based in the UK working in equitable partnerships with LMIC investigators. 
- Applicants must have a relevant academic affiliation to an eligible institution in an LMIC or the UK.
- For researchers based in LMICs, eligible institutions include Higher Education Institutions and not-for-profit research institutions.
- Proposals must have a lead administering organisation eligible to accept and administer funds from NIHR and UKRI

Tipo de financiación: Research

➡️ Más información: https://bit.ly/2NHOZT9 

Fecha de cierre: 10/8/2020 

Objetivo: to support applied health research that will address COVID-19 knowledge gaps.  The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income countries (LMIC) contexts.The call specification is based on the WHO COVID-19 Global Research Roadmap priorities identified through a consultative process that involved experts from across the world. 

Líneas temáticas:

1. Describe transmission dynamics of COVID-19 and understand spread of disease nationally, regionally and globally. 
2. Describe disease severity and susceptibility to facilitate effective clinical and public health response to COVID-19.
3. Evaluate impact of control and mitigation measures.

Requisitos: 

- Applications are particularly encouraged from LMIC PIs, as well as PIs based in the UK working in equitable partnerships with LMIC investigators. 
- Applicants must have a relevant academic affiliation to an eligible institution in an LMIC or the UK.
- For researchers based in LMICs, eligible institutions include Higher Education Institutions and not-for-profit research institutions.
- Proposals must have a lead administering organisation eligible to accept and administer funds from NIHR and UKRI

Tipo de financiación: Research

➡️ Más información: https://bit.ly/2NHOZT9 

Fecha de cierre: Sin fecha de cierre

Objetivo: Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak in Low and Middle Income Countries

Líneas temáticas:

Epidemiological studies
Clinical characterization and management
Infection prevention and control including health care workers’ protection
Social Sciences in the Outbreak Response (access to health care services/vaccination etc) NOT socio-economic generally

Requisitos:

We strongly encourage applicants from LMIC countries to apply to and participate in this call. LMIC country Principal Investigators from an organisation that lead or have previously led and held UKRI grants and have undergone Je-S registration and due diligence checks are eligible to be lead applicants for this call. The LMIC-based organisation must be able to receive and manage funds from UKRI via a grant and must ensure their application complies with local regulations and has the necessary local approvals.

Tipo de financiación: Research

➡️ Más información: https://bit.ly/3e2MndK

Fecha de apertura 19 de marzo de 2020
Fecha de cierre: 1 de septiembre de 2020

Objetivo: The effects of the current SARS-CoV-2 outbreak have shown that epidemics and pandemics cannot be managed on a solely national level; instead, the global framework needs to be taken into account.
To be better prepared for the diverse aspects of global waves of infection, it is essential to support wide-ranging research across different disciplines. In addition to investigating the current pandemic, it is important to identify fundamental research questions that produce generalizable scientific findings.

Líneas temáticas:
The challenges and effects of an epidemic or pandemic and of measures taken for healthcare systems; psychological, social and cultural factors in the emergence, spread and treatment of epidemics and pandemics and the legal and ethical implications.
The impacts on global and regional economic development, production and value creation chains, logistics, transport and communication.
Fundamental biological and medical aspects of a pathogen and the associated symptoms, as well as therapeutic methods or preventive measures in combination with one or more of the above topic areas.

Requisitos:
Researchers who would like to submit an individual proposal, a joint proposal or a proposal package are requested to contact the DFG Head Office as early as possible for advice. Proposals will be reviewed on a comparative basis and with the participation of an international group of reviewers in accordance with the DFG's standard review processes. To enable the DFG to plan the review process, applicants must submit letters of intent outlining the research project (max. 200 words) and listing the names of all applicants.

Tipo de financiación: Funding is available for individual or joint proposals in the form of individual research grants or proposal packages. To achieve a project’s objectives, all funding modules listed in the Guidelines for the Research Grants Programme (DFG form 50.01) can be requested.

The DFG will support scientific dialogue and networking between grant recipients during the course of the projects.

➡️ Más información: https://bit.ly/2XQgQX7

Fecha de cierre: 3 septiembre 2020 14:00

Objetivo:

This call aims to increase society’s preparedness and resilience in order to address future crises. The call will help increase our understanding of the impacts of Covid-19 and the opportunities for transformation and recovery in the face of crises. This will be done through research that explores the current situation that the novel coronavirus has confronted us with, as well as the potential for transformation that it brings.

Líneas temáticas:

The call focuses on the lessons we can learn from the pandemic. What long-term impacts can we expect due to the current circumstances? What can be learned with regard to future climate change, a sustainable food system and more sustainable communities?

Requisitos:
-Participating researchers must also have obtained their PhD degree by the time the call closes. Other staff involved in the project do not need to have a PhD degree.
-The proposed grant recipient must be stated as a project manager on the application.
-Grants may only be administered by a Swedish university, college or other Swedish public organisation that meets Formas’ criteria for administrating organisations.
-There is no upper age limit for the main applicant and participating researchers. However, researchers who are full-time pensioners are not eligible to receive funding towards salaries.

Tipo de financiación: Research

Más información: https://bit.ly/2YKvyQ6

Fecha de apertura: 04 agosto 2020
Fecha de cierre: 04 septiembre 2020

Objetivo: The NIH Director's Early Independence Award (a component of the High-Risk, High-Reward
Research program of the NIH Common Fund) supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.

Líneas temáticas:

Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Early Independence Awards (through this FOA) or Transformative Research Awards (through RFA-RM-20-020) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally.

Requisitos:

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R)
Application Guide,except where instructed to do otherwise (in this FOA or in a Notice from NIH Guide for Grants and Contracts)

Tipo de financiación: Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.

➡️ Más información: https://bit.ly/36He2hT

Fecha de cierre: 30 septiembre 2020

Objetivo:

The Health Foundation has launched a new research programme, which seeks to understand the impact of the COVID-19 pandemic in two distinct areas. This programme aligns with our strategic priorities and complements the existing research funding landscape.  

Líneas temáticas:

1.How health and social care service delivery has changed in light of COVID-19 
2.the impact of COVID-19 on health inequalities and the wider determinants of health. 

Requisitos:
-Strong alignment with the priority areas of this call. 
-Addressing a pressing COVID-19 related knowledge gap, with findings that will be relevant to policy/service delivery decisions. 
-Value for money. 
-A researcher or team with the right strengths, expertise and credibility to deliver the research.
-A strong, robust research methodology that is feasible and well-planned. 

Tipo de financiación:Research

➡️ Más información: https://bit.ly/3ikbQCo 

Fecha de cierre:

Cut-off date for HT COVID-19 ideas - 1600 BST - 23 July 2020 
New HTs announced, feedback on ideas available - November 2020

Objetivo: NERC invites highlight topic ideas (strategic funding for research and innovation) to encourage environmental solutions that learn from the COVID-19 pandemic, and in doing so support the UK environment, economy and society to recover from COVID-19 legacy challenges..

Líneas temáticas:

Environmental solutions that learn from the COVID-19 pandemic

Requisitos:

Guidance for developing and submitting ideas for strategic research highlight topics in the following link: https://bit.ly/3dRSEsi 

Tipo de financiación: Research

➡️ Más información: https://bit.ly/31yCMZq 

Fecha de cierre: February 02, 2021

Objetivo: This GCRF/Newton Fund call focuses upon mitigating both short and longer-term impacts of COVID-19 on health, wellbeing, community cohesion, and economic prosperity. In the health sphere, mental health, health economics, and malnutrition are all impacted by the virus and require interdisciplinary research.

Líneas temáticas:

1.Efficacy and safety of interventions that target aging-related biological mechanisms that may influence risk or severity of COVID-19 infection among at-risk older adults.

2.Efficacy and safety of preventive and treatment interventions in older patients with differing comorbid conditions that make them especially vulnerable to adverse outcomes of COVID-19 infection.

3.Effectiveness of health and/or custodial care practices to reduce transmission risk or improve outcomes of COVID-19 infection in nursing homes or other residential settings serving at-risk older persons, including the development and testing of infection control training procedures for healthcare workers.

4.Rapid pragmatic trials in (at least two) health systems, nursing homes, or adult living facilities, ensuring replication across large pragmatic trial sites and leveraging electronic health records to promote quality improvement in physician, hospital, palliative care, and hospice practices to improve outcomes for older patients with COVID-19, especially those with cognitive impairment, Alzheimer's disease or Alzheimer's disease-related dementias (AD/ADRD), or underlying comorbidities.

5.Trials in at-risk older adults age 65 and older for whom electronic medical records are available and long-term outcomes can be tracked, and in institutions serving those populations.

6.Trials in older adults with AD/ADRD, older adults from populations with NIH-defined health disparities, and/or other vulnerable populations (e.g. incarcerated, homeless, living in institutions)

Requisitos:

-Sistema de numeración universal Dun and Bradstreet (DUNS) : todas las inscripciones requieren que los solicitantes reciban un número DUNS. Después de obtener un número DUNS, los solicitantes pueden comenzar los registros de SAM y eRA Commons. Se debe utilizar el mismo número DUNS para todos los registros, así como en la solicitud de subvención.

-Sistema de gestión de premios (SAM) : los solicitantes deben completar y mantener un registro activo, que requiere renovación al menos una vez al año. El proceso de renovación puede requerir tanto tiempo como el registro inicial. El registro de SAM incluye la asignación de un Código de Entidad Comercial y Gubernamental (CAGE) para organizaciones nacionales a las que aún no se les ha asignado un Código CAGE. o Código de la OTAN de Entidades Comerciales y Gubernamentales (NCAGE) : las organizaciones extranjeras deben obtener un código NCAGE (en lugar de un código CAGE) para registrarse en SAM.

-eRA Commons: los solicitantes deben tener un número DUNS activo para registrarse en eRA Commons. Las organizaciones pueden registrarse en eRA Commons mientras trabajan a través de su registro SAM o Grants.gov, pero todos los registros deben estar vigentes al momento de la presentación. eRA Commons requiere que las organizaciones identifiquen al menos un Oficial de firma (SO) y al menos una cuenta de Director de programa / Investigador principal (PD / PI) para enviar una solicitud.

-Grants.gov: los solicitantes deben tener un número DUNS activo y registro SAM para completar el registro Grants.gov.

More information in the following link: https://bit.ly/38ef1XW 

Tipo de financiación: Research

➡️ Más información: https://bit.ly/38ef1XW 

Fecha de cierre: April 30, 2021

Objetivo: The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus.

Líneas temáticas:

- Studies to understand critical aspects of viral infection, replication and pathogenesis
- Studies to understand critical aspects of viral transmission
- Identification and characterization of the onset and duration of immunity in healthy and at-risk populations
- Development of SARS-CoV-2-specific or broadly protective coronavirus vaccine candidates

Requisitos:

- Program Directors/Principal Investigators (PD(s)/PI(s))
- All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
- Eligible Individuals (Program Director/Principal Investigator)
- Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

Tipo de financiación: Research

➡️ Más información: https://bit.ly/2Z7toue

Fecha de cierre: none - apply at any time

Objetivo:

Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak.

Líneas temáticas:

- New research or innovation with a clear impact pathway that has the potential (within the period of the grant) to deliver a significant contribution to the understanding of, and response to, the COVID-19 pandemic and its impacts.
- Supports the manufacture and/or wide scale adoption of an intervention with significant potential
- Gathers critical data and resources quickly for future research use

Requisitos: you can see all the requirements in the following link: https://bit.ly/2Z7MxMZ

Tipo de financiación:Research

➡️ Más información: https://bit.ly/3fN6rmd

Fecha de cierre: up to 18 months

Objetivo: This GCRF/Newton Fund call focuses upon mitigating both short and longer-term impacts of COVID-19 on health, wellbeing, community cohesion, and economic prosperity. In the health sphere, mental health, health economics, and malnutrition are all impacted by the virus and require interdisciplinary research.

Líneas temáticas:

- New research or innovation with a clear pathway to impact on policy or practice that has the potential (within the period of the award) to deliver a significant contribution to the understanding of, response to, and recovery from the COVID-19 pandemic in a developing country context.
- Supports the manufacture and/or wide scale adoption of an intervention with significant potential for impact in developing countries.
- Gathers critical data and resources quickly for future research use.

Requisitos:

This call will cover 100% fEC costs for Principal and Co-Investigators from LMICs. This applies to Investigators from Low and Middle Income Countries identified on the OECD DAC list of ODA recipients.

Tipo de financiación: Research

➡️ Más información: https://bit.ly/2WxUDgc

Fecha de cierre: 31/07/2020

Objetivo: En el periodo de 2020-2021 la AIUP continua con el objetivo de facilitar la protocolización y funcionamiento pleno de las redes ya constituidas y, por otro lado, apoyar y fomentar la conformación de nuevas redes con una distribución en áreas de conocimiento estratégicas en el entorno del Espacio Iberoamericano del Conocimiento (EIC), así como en su relación con la Agenda 2030 y los Objetivos de Desarrollo Sostenible (ODS).

Líneas temáticas:

Estas Redes Iberoamericanas de Investigadores deben buscar la complementariedad
de las capacidades, los recursos de investigación existentes o la transferencia y difusión de sus resultados, entre grupos de investigación de las distintas instituciones de Iberoamérica y, de este modo, contribuir a la generación de sinergias que sirvan para la creación de nuevas redes o el apoyo y consolidación de las vinculadas con la AUIP, en ámbitos estratégicos y novedosos para el fortalecimiento del Espacio Iberoamericano del Conocimiento, así como para el cumplimento de los Objetivos de Desarrollo Sostenible.

Requisitos: Asimismo, las obligaciones y condiciones de los beneficiarios, en función del tipo de ayuda que soliciten, son las siguientes:
- En el caso de la creación de una NUEVA RII.
- La página debe tener un dominio de red propio, que la identifique de forma única como ente
independiente.
- La Red Iberoamericana de Investigadores debe de disponer de una imagen corporativa y, en su caso, el diseño de la página debe estar al nivel del resto de las redes promovidas por la AUIP.
- Como Red Iberoamericana de Investigadores vinculada a la AUIP, ésta debe figurar como
institución patrocinadora y/o colaboradora, poniendo el logo en lugar visible con un enlace
directo al sitio web de la Asociación. Asimismo, en la página de la AUIP habrá un enlace que
conecte directamente a la web de la Red.
Para el apoyo y consolidación de una RII AUIP.
- En ningún caso se concederá financiación para eventos ya realizados.
- La AUIP deberá figurar como una de las entidades organizadoras y/o promotoras del evento.

Tipo de financiación: 70% (except for non-profit legal entities, where a rate of 100% applies)

➡️ Más información: https://bit.ly/2X8oLij